Physical Activity Linked to Attenuation of Colon Cancer Survival Disparity
By Elana Gotkine HealthDay Reporter
MONDAY, Feb. 24, 2025 -- For patients with stage III colon cancer participating in clinical trials, physical activity is associated with an attenuation of the survival disparity relative to the matched general population (MGP), according to a study published online Feb. 24 in Cancer.
Justin C. Brown, Ph.D., from the Pennington Biomedical Research Center in Baton Rouge, Louisiana, and colleagues analyzed data from two National Cancer Institute-sponsored postoperative treatment trials (Cancer and Leukemia Group B [CALGB] 89803 and 80702) of stage III colon cancer involving 2,876 patients who selfâreported physical activity.
The researchers found that among patients who were alive at three years in CALGB 89803, those with <3.0 and ≥18.0 metabolic-equivalent (MET)-hours per week had subsequent overall survival rates that were −17.1 and −3.5 percent lower, respectively, than the MGP derived from the National Center for Health Statistics. The corresponding three-year overall survival rates in CALGB 80702 were −10.8 and −4.4 percent lower than the MGP. In pooled analyses of 1,908 patients who were alive and did not have tumor recurrence by year 3, subsequent three-year overall survival rates were −3.1 percent lower and 2.9 percent higher than the MGP for those with <3.0 and ≥18.0 MET-hours/week, respectively.
"Among patients with stage III colon cancer enrolled in trials of postoperative treatments, participation in physical activity was associated with an attenuation of the survival disparity between colon cancer patients and the MGP," the authors write. "Achieving a survival rate comparable to the MGP is conditional on remaining tumor recurrence-free."
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
CRC as First of Multiple Primary Malignancies Tied to Better Outcomes Than CRC as Only Malignancy
THURSDAY, June 26, 2025 -- Compared with colorectal cancer (CRC) presenting as an isolated primary or second primary malignancy, CRC presenting as the first of multiple primary...
Two-Hour Observation Probably Safe for Most Children With Anaphylaxis
THURSDAY, June 26, 2025 -- For most children who present to an emergency department with an acute allergic reaction requiring epinephrine, a two-hour observation period is...
CT Perfusion and CT Angiography Not Useful as Standalone Tests for Establishing Death by Neurologic Criteria
THURDAY, June 26, 2025 -- Neither computed tomography (CT) perfusion nor CT angiography meet the prespecified validation threshold as an ancillary test for death by neurologic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.